Published in Q J Med on January 01, 1975
Policy for early discharge after acute myocardial infarction. Br Med J (1980) 1.19
Effect of intravenous insulin infusion on mortality among diabetic patients after myocardial infarction. Br Heart J (1984) 1.14
Diabetic cardiomyopathy: the preclinical phase. Br Med J (1977) 1.07
Is there evidence that oral hypoglycemic agents reduce cardiovascular morbidity or mortality? No. Diabetes Care (2009) 0.87
The heart in diabetes. West J Med (1984) 0.85
Twenty-four hour monitoring of heart rate and activity in patients with diabetes mellitus: a comparison with clinic investigations. Br Med J (1976) 0.80
Gender differences in clinical status at time of coronary revascularisation in Spain. J Epidemiol Community Health (2002) 0.77
Glucose intolerance, diabetes mellitus and atherosclerosis; prospects for prevention. Postgrad Med J (1976) 0.77
Insulin treatment increases myocardial ceramide accumulation and disrupts cardiometabolic function. Cardiovasc Diabetol (2015) 0.76
Editorial: Diabetic hearts and biguanides-a reply. Can Med Assoc J (1976) 0.75
Genomics. Genome project standards in a new era of sequencing. Science (2009) 7.72
Practolol in treatment of angina pectoris. A double-blind trial. Br Med J (1970) 3.43
A milestone for myocardial infarction. BMJ (1988) 3.42
The establishment of a normal human population dose-response curve for lymphocytes cultured with PHA (phytohaemagglutinin). Clin Exp Immunol (1971) 3.09
Antibody avidity determination by ELISA using thiocyanate elution. J Immunol Methods (1986) 3.07
Diabetic clinic in a general practice. Br Med J (1971) 2.71
Results of a general hospital coronary care service. Br Med J (1968) 2.70
Quantitative study of infarcted myocardium in cardiogenic shock. Br Heart J (1970) 2.29
Natural history and clinical significance of arrhythmias after acute cardiac infarction. Br Heart J (1967) 2.13
Immunoglobulin response to intravenous streptokinase in acute myocardial infarction. Br Heart J (1991) 2.12
Coronary care for myocardial infarction in diabetics. Lancet (1974) 2.12
Proteinuria with streptokinase. Lancet (1993) 2.01
Trajectories of alcohol consumption following liver transplantation. Am J Transplant (2010) 2.01
Congenital malformations in infants of diabetic mothers. Q J Med (1976) 1.94
Quantified deficiency of lymphocyte response to phytohaemagglutinin in immune deficiency diseases. Clin Exp Immunol (1971) 1.89
Very pure porcine insulin in clinical practice. Br Med J (1979) 1.81
Fibrous disease of the breast, thyroiditis, and cheiroarthropathy in type I diabetes mellitus. Lancet (1984) 1.80
Cultivar-specific avirulence and virulence functions assigned to avrPphF in Pseudomonas syringae pv. phaseolicola, the cause of bean halo-blight disease. EMBO J (2000) 1.76
Motives and decision making of potential living liver donors: comparisons between gender, relationships and ambivalence. Am J Transplant (2011) 1.73
Globin Insulin: Clinical Trial. Br Med J (1945) 1.57
Fatal Diabetic Ketosis. Br Med J (1961) 1.46
Association of foot lesions with retinopathy in patients with newly diagnosed diabetes. Lancet (1975) 1.44
Characterization of avrPphE, a gene for cultivar-specific avirulence from Pseudomonas syringae pv. phaseolicola which is physically linked to hrpY, a new hrp gene identified in the halo-blight bacterium. Mol Plant Microbe Interact (1995) 1.37
Retinopathy at diagnosis of diabetes, with special reference to patients under 40 years of age. Br Med J (1969) 1.35
Acetone in diabetic ketoacidosis. Lancet (1970) 1.34
The pattern of onset and spontaneous cessation of atrial fibrillation in man. Circulation (1970) 1.30
Rubella virus and human lymphocytes in culture. Lancet (1968) 1.29
Rapid and reliable fluorescent cycle sequencing of double-stranded templates. DNA Seq (1992) 1.28
Sequence variations in alleles of the avirulence gene avrPphE.R2 from Pseudomonas syringae pv. phaseolicola lead to loss of recognition of the AvrPphE protein within bean cells and a gain in cultivar-specific virulence. Mol Microbiol (1998) 1.26
Why do patients develop reactions to streptokinase? Clin Exp Immunol (1993) 1.23
Value of glycosylated hemoglobin measurements after acute myocardial infarction. JAMA (1981) 1.22
Diabetic diarrhea. A study of thirteen patients with jejunal biopsy. Diabetes (1969) 1.21
Replication error phenotype, clinicopathological variables, and patient outcome in Dukes' B stage II (T3,N0,M0) colorectal cancer. Gut (2000) 1.21
Comparative study of different insulin regimens in management of diabetic ketoacidosis. Lancet (1975) 1.20
The Birmingham blood pressure school study. Postgrad Med J (1983) 1.19
Influence of racial origin on admission rates of patients with suspected myocardial infarction in Birmingham. Br Heart J (1991) 1.17
Trial of combined intramuscular and intravenous lignocaine in prophylaxis of ventricular tachyarrhythmias. Lancet (1972) 1.17
Intensive care in the management of diabetic ketoacidosis. Lancet (1973) 1.17
A satisfactory quantitative test of lymphocyte response to phytohaemagglutinin for the definition of normal control values and recognition of immunological defects. J Clin Pathol (1972) 1.16
A female child with five X chromosomes. J Pediatr (1967) 1.15
Effect of intravenous insulin infusion on mortality among diabetic patients after myocardial infarction. Br Heart J (1984) 1.14
Controlled trial of lignocaine in prophylaxis of ventricular arrhythmias complicating myocardial infarction. Lancet (1970) 1.13
Lactic acidosis in diabetes. Br Med J (1969) 1.11
Beta-adrenergic blockade in experimental myocardial infarction. Am Heart J (1966) 1.10
The natural history of diabetic renal disease. A follow-up study of a series of renal biopsies. Q J Med (1972) 1.09
Organization of a coronary care unit in a general hospital. Br Med J (1967) 1.08
Changes in systolic time intervals during treatment of diabetes mellitus. Br Heart J (1977) 1.08
Plasma inhibitors of lymphocyte response to phytohaemagglutinin in children with recurrent infections. Immunology (1976) 1.06
Insulin antibodies and the control of diabetes. Q J Med (1975) 1.05
Controlled trial of intravenous glucose, potassium, and insulin in acute myocardial infarction. Lancet (1968) 1.04
Use of low-dose insulin infusions in diabetics after myocardial infarction. Br Med J (Clin Res Ed) (1982) 1.03
Alcohol use following liver transplantation: a comparison of follow-up methods. Psychosomatics (2001) 1.03
Early trajectories of depressive symptoms after liver transplantation for alcoholic liver disease predicts long-term survival. Am J Transplant (2011) 1.02
Chromosomal assignment of 46 brain cDNAs. Genomics (1992) 1.01
Psychosocial assessments and outcomes in organ transplantation. Prog Transplant (2000) 0.99
Hydatidiform Mole and Coexistent Foetus, both with Triploid Chromosome Constitution. Br Med J (1967) 0.99
Reappraisal of lignocaine therapy in management of myocardial infarction. Br Heart J (1981) 0.99
The significance of anti-streptokinase antibodies. Clin Exp Immunol (1994) 0.99
The effect of maintenance dialysis on lymphocyte function. I. Haemodialysis. Clin Exp Immunol (1978) 0.96
Report of the task force on the implications for darkly pigmented intact skin in the prediction and prevention of pressure ulcers. Adv Wound Care (1996) 0.96
Intravenous and oral practolol in the acute stages of myocardial infarction. Eur J Cardiol (1978) 0.95
A pregnant patient with Eisenmenger's syndrome. Case report. Br J Anaesth (1971) 0.94
Low-dose insulin treatment of hyperosmolar diabetic coma. Postgrad Med J (1981) 0.94
Mechanism of lymphocyte transformation induced by phytohaemagglutinin. Nature (1968) 0.93
Diabetes mellitus and primary hyperparathyroidism. Postgrad Med J (1975) 0.93
Is impaired baroreflex sensitivity a predictor or cause of sudden death in insulin-dependent diabetes mellitus? Diabet Med (1997) 0.93
Potassium balance during treatment of diabetic ketoacidosis with special reference to the use of bicarbonate. Lancet (1972) 0.93
Myocardial infarct size and mortality in diabetic patients. Br Heart J (1985) 0.93
Hyperosmolar hyperglycemic nonketotic syndrome. Report of 22 cases and brief review. Am J Med (1984) 0.92
Modification of the mandibular ramus sagittal split osteotomy. Oral Surg Oral Med Oral Pathol (1987) 0.92
Menstruation and control of diabetes. Br Med J (1977) 0.92
Warning of cardiac arrest due to ventricular fibrillation and tachycardia. Lancet (1972) 0.91
Value of serum glucose assay as part of the biochemical profile in screening for diabetes. Ann Clin Biochem (1982) 0.91
Changes in beta 1- and beta 2-adrenergic receptor mRNA levels in brown adipose tissue and heart of hypothyroid rats. Biochem J (1991) 0.91
A logbook system for monitoring student skills and experiences. J Med Educ (1981) 0.89